Mass General Brigham, Inc

SOMERVILLE, MA · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 3, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$456.3M2026 Q3
Positions9
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.100.0%

Mass General Brigham, Inc reported 9 positions worth $456.3M as of September 30, 2026 (13F filed November 3, 2026). Largest holding: VT (65.8%). Biggest move: new buy VT ($300.5M).

9 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 VTVanguard Intl Equity$300.5M65.85%1,898,645——-3.5%
▸ 2 RVMDRevolution Medicines$70.6M15.48%344,091——-18.7%
▸ 3 SPCXSpace Exploration Technologies$35.3M7.74%234,140——-8.9%
▸ 4 LYNXLyntris$23.6M5.17%1,916,964——+9.4%
▸ 5 TNGXTango Therapeutics$8.8M1.94%354,192——-3.1%
▸ 6 MAZEMaze Therapeutics$6.8M1.49%249,636——+24.7%
▸ 7 KRMNKarman$6.8M1.49%209,261——+15.6%
▸ 8 MDLNMedline$2.4M0.52%68,413——+12.9%
▸ 9 IOTSamsara$1.5M0.33%39,772——+7.1%

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does Mass General Brigham, Inc hold as of Q3 2026?

Mass General Brigham, Inc reported 9 positions worth $456.3M in its Q3 2026 13F filing. Largest positions: VT (65.8%), RVMD (15.5%), SPCX (7.7%), LYNX (5.2%) and TNGX (1.9%).

What did Mass General Brigham, Inc buy in Q3 2026?

New positions: VT, SPCX, LYNX and IOT. Added to: MAZE.

What did Mass General Brigham, Inc sell in Q3 2026?

Reduced: KRMN. Sold out entirely: ACWI.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.